Jestycold multi-ingredient formulation combines four well-established agents—Paracetamol, Phenylephrine, Caffeine and Diphenhydramine—designed to offer broad, complementary support in conditions where combined symptom relief is considered appropriate by healthcare professionals. Each component contributes a specific functional role, creating a balanced profile ideal for use in common cold and related upper-respiratory discomfort when recommended by a physician. Paracetamol is widely recognized for its analgesic and antipyretic properties, helping alleviate mild to moderate pain and discomfort while supporting temperature regulation. Phenylephrine, a selective nasal decongestant, acts on adrenergic receptors to help reduce nasal blockage and improve airflow. Caffeine is included as a stimulant adjunct; it may enhance alertness, counteract fatigue, and is often used to augment the pain-relieving effect of analgesic agents. Diphenhydramine, a first-generation antihistamine, supports relief from symptoms associated with histamine response, such as sneezing, runny nose, and irritation, while also providing mild sedative action that can ease nighttime discomfort. This combination is commonly chosen in clinical settings for its multi-symptom coverage, offering an integrated approach in a single tablet. The formulation is designed for convenient oral administration with consistent disintegration and absorption profiles that support predictable performance. It is typically utilized when a healthcare provider determines that the combined benefits of analgesia, decongestion, antihistaminic action, and supportive stimulation are suitable for the patient’s condition. Use of this medication should follow professional medical advice, with attention to appropriate dosage, duration, and individual health considerations. As with all combination preparations, responsible use helps ensure safety and effectiveness while minimizing the potential for unnecessary exposure to active ingredients.
| Packing | 20*10 (Blister) |
| GST | 5% |